Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Thorax|September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluationIdan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Health Technology Assessment (Winchester, England)|February 28, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)M J Crawford, H Killaspy, T R Barnes, et al.
ERJ Open Research|February 12, 2021
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumoniaRebecca F D'Cruz, Michael D Waller, Felicity Perrin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individualsE De Wachter, K De Boeck, I Sermet-Gaudelus, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disordersN J Simmonds, K W Southern, E De Wachter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
Frontiers in Immunology|January 5, 2023
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignanciesNatasha Kekre, Kevin A Hay, John R Webb, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 31